» Articles » PMID: 36339329

Use of Fresh-frozen Plasma in Newborn Infants

Overview
Date 2022 Nov 7
PMID 36339329
Authors
Affiliations
Soon will be listed here.
Abstract

Nearly 10% of premature and critically ill infants receive fresh-frozen plasma (FFP) transfusions to reduce their high risk of bleeding. The authors have only limited data to identify relevant clinical predictors of bleeding and to evaluate the efficacy of FFP administration. There is still no consensus on the optimal use of FFP in infants who have abnormal coagulation parameters but are not having active bleeding. The aims of this review are to present current evidence derived from clinical studies focused on the use of FFP in neonatology and then use these data to propose best practice recommendations for the safety of neonates receiving FFP.

References
1.
Castaman G, Linari S . Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders. J Clin Med. 2017; 6(4). PMC: 5406777. DOI: 10.3390/jcm6040045. View

2.
Hofer J, Fries D, Solomon C, Velik-Salchner C, Ausserer J . A Snapshot of Coagulopathy After Cardiopulmonary Bypass. Clin Appl Thromb Hemost. 2016; 22(6):505-11. DOI: 10.1177/1076029616651146. View

3.
Dzik W, Rao A . Why do physicians request fresh frozen plasma?. Transfusion. 2004; 44(9):1393-4. DOI: 10.1111/j.0041-1132.2004.00422.x. View

4.
Westphal R, Tindle B, Howard P, Golden E, Page G . Rapid thawing of fresh frozen plasma. Am J Clin Pathol. 1982; 78(2):220-2. DOI: 10.1093/ajcp/78.2.220. View

5.
McMichael A, Zimmerman K, Kumar K, Ozment C . Evaluation of effect of scheduled fresh frozen plasma on ECMO circuit life: A randomized pilot trial. Transfusion. 2020; 61(1):42-51. DOI: 10.1111/trf.16164. View